Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Dicerna Pharmaceuticals Company Profile (NASDAQ:DRNA)

Consensus Ratings for Dicerna Pharmaceuticals (NASDAQ:DRNA) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $44.33 (180.95% upside)

Analysts' Ratings History for Dicerna Pharmaceuticals (NASDAQ:DRNA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/14/2014Stifel NicolausReiterated RatingBuy$53.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2014Leerink SwannLower Price TargetOutperform$60.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014ZacksInitiated CoverageHoldViewTweet This Rating  Share This Rating on StockTwits
2/24/2014Leerink SwannInitiated CoverageOutperform$60.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2014Stifel NicolausInitiated CoverageBuy$53.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2014Robert W. BairdInitiated CoverageNeutral$41.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2014Jefferies GroupInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2012 forward)